High Speed Downlink Packet Access (HSDPA) is a cellular system that was standardized by the 3rd Generation Partnership Project (3GPP). HSDPA can support data rates of up to 14.4 Mbps through the use of a shared channel. Due to its high transmission rates, the highly popular multimedia applications are converging over this network. Moreover, as the shared channel is assigned to a single user in a given time interval, the scheduling decision is considered as a crucial one. Conventional HSDPA scheduling schemes utilize the fluctuations in channel condition to maximize system throughput by selecting users with relatively good radio conditions. However, this raises the issue of fairness as users with relatively poor channel conditions might not be served and consequently may suffer from starvation. Furthermore, Real-Time (RT) applications have strict delay constraints and require that packets are transmitted within a certain delay threshold. In this thesis, a Delay Based Scheduler (DBS) is proposed for HSDPA which aims at minimizing the average queuing delay at the packet scheduler without compromising system throughput and fairness. In addition, the scheme can balance the tradeoff between throughput maximization and the minimization of queuing delay through the attunement of a parameter, thus allowing the service provider to choose between these two metrics. The DBS maintains the delay constraints of RT applications by defining delay thresholds for each traffic class and dropping packets that exceed their delay limit. The DBS accommodates Quality of Service (QoS) prioritization by defining and utilizing desired QoS parameters in the scheduling assignment. Finally, it was mathematically shown that the DBS can converge to a Non-Real-Time (NRT) scheme known as the Max CIR algorithm, allowing the scheduler to support RT and NRT applications simultaneously. The performance of the DBS was evaluated and compared to other well known schemes. It was found that the DBS can minimize the aggregate queuing delay of the system and maintain similar throughput and fairness. / Thesis (Master, Computing) -- Queen's University, 2007-08-15 16:12:36.22

The concept of charisma, while gaining greater usage in contemporary society, is under-researched and often misused. This thesis discusses the classical theoretical conception of charisma, beginning with Max Weber, and provides three empirical illustrations of charismatic leadership in the fields of religion, politics, and the media.

The concept of charisma, while gaining greater usage in contemporary society, is under-researched and often misused. This thesis discusses the classical theoretical conception of charisma, beginning with Max Weber, and provides three empirical illustrations of charismatic leadership in the fields of religion, politics, and the media.

Effective therapeutics are urgently needed to improve the treatment and survival of cancer patients and we believe that targeting the MYC oncogene would fill this gap. Our strategy to achieve this goal involves the design of minimalist hybrid protein inhibitors (MHP) - 25-75 amino acid proteins composed of subdomains of known transcription factor families to generate hybrids that act as structural competitive inhibitors of the Myc/Max:DNA E-box interaction. We have established cell systems, reagents and assays using our prototype MHP, ME47 to evaluate the biological effectiveness of this putative inhibitor as well as subsequently designed MHPs using cell-based proliferation and transformation assays. Omomyc was included as a proof-of-concept control to optimize our systems and gauge the performance of ME47. This research demonstrates for the first time that ME47 exerts desirable biological effects in human cells lines and provides support for the validity of our MHP strategy thus warranting further investigation.

Effective therapeutics are urgently needed to improve the treatment and survival of cancer patients and we believe that targeting the MYC oncogene would fill this gap. Our strategy to achieve this goal involves the design of minimalist hybrid protein inhibitors (MHP) - 25-75 amino acid proteins composed of subdomains of known transcription factor families to generate hybrids that act as structural competitive inhibitors of the Myc/Max:DNA E-box interaction. We have established cell systems, reagents and assays using our prototype MHP, ME47 to evaluate the biological effectiveness of this putative inhibitor as well as subsequently designed MHPs using cell-based proliferation and transformation assays. Omomyc was included as a proof-of-concept control to optimize our systems and gauge the performance of ME47. This research demonstrates for the first time that ME47 exerts desirable biological effects in human cells lines and provides support for the validity of our MHP strategy thus warranting further investigation.

Thesis (M.A.)--Trinity Evangelical Divinity School, 1988. / Abstract lacking from microfiche. Includes bibliographical references (leaves 99-104).

Thesis (Ph.D.)--McMaster University, 1999. / Includes bibliographical references (leaves 301-316). Also available via World Wide Web.

Zugl.: Bonn, Univ., Diss., 2003

Thesis (Ph.D.)--University of Melbourne, Dept. of Fine Arts, Classical Studies and Archaeology, 1999. / Typescript (photocopy). Includes bibliographical references (leaves 294-326).

Thesis (M.A. (Art History)) -- University of Adelaide, 2002. / Bibliography: leaf 83-86.